Latest stories on CLLS
Cellectis to Report Second Quarter Financial Results on August 6, 2026
Business Insider50 · neutralgeneral
Cellectis to Report Second Quarter Financial Results on August 6, 2026 | CLLS Stock News
StockTitan50 · neutralgeneral
Monthly information on share capital and company voting rights | CLLS Stock News
StockTitan50 · neutralgeneral
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 | CLLS Stock News
StockTitan50 · neutralgeneral
Biggest stock movers Wednesday: CBRL, CLLS, SMCI, trucking stocks, and more
Seeking Alpha50 · neutralgeneral
Cellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
TipRanks73 · bullishproduct/pr
Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress | CLLS Stock News
StockTitan67 · bullishproduct/pr
Biggest stock movers Wednesday: CBRL, CLLS, SMCI, chip stocks, and more
Seeking Alpha48 · neutralgeneral
Cellectis wins FDA RMAT status for leukemia CAR-T candidate lasme-cel; shares rise
Seeking Alpha73 · bullishproduct/pr
CLLS Stock Rallies Over 24% After Hours — Here's Why
Stocktwits News73 · bullishproduct/pr
Cellectis Gains FDA RMAT Status for Allogeneic CAR-T lasme-cel in r/r B-ALL
TipRanks73 · bullishproduct/pr
Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL
Business Insider73 · bullishproduct/pr
Monthly information on share capital and company voting rights | CLLS Stock News
StockTitan50 · neutralgeneral
CLLS: [6-K] Cellectis S.A. Current Report (Foreign Issuer)
StockTitan SEC50 · neutralgeneral
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026 | CLLS Stock News
StockTitan50 · neutralgeneral
Cellectis Reports Financial Results for the First Quarter 2026
GlobeNewswire50 · neutralearnings